These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23403711)

  • 21. Clinicians' views regarding deactivation of cardiovascular implantable electronic devices in seriously ill patients.
    Mueller PS
    Heart Rhythm; 2010 Nov; 7(11):1543-4. PubMed ID: 20816871
    [No Abstract]   [Full Text] [Related]  

  • 22. [Implantable automatic defibrillators and their deactivation, a necessary conversation. Literature review].
    Cerda T; Crispino L; Paredes A
    Rev Med Chil; 2023 Oct; 151(10):1399-1405. PubMed ID: 39093143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deactivation of advanced lifesaving technologies.
    Lipman HI
    Am J Geriatr Cardiol; 2007; 16(2):109-11. PubMed ID: 17342011
    [No Abstract]   [Full Text] [Related]  

  • 24. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.
    Padeletti L; Arnar DO; Boncinelli L; Brachman J; Camm JA; Daubert JC; Hassam SK; Deliens L; Glikson M; Hayes D; Israel C; Lampert R; Lobban T; Raatikainen P; Siegal G; Vardas P; ; Kirchhof P; Becker R; Cosio F; Loh P; Cobbe S; Grace A; Morgan J; ;
    Europace; 2010 Oct; 12(10):1480-9. PubMed ID: 20675674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association.
    Wilkoff BL; Auricchio A; Brugada J; Cowie M; Ellenbogen KA; Gillis AM; Hayes DL; Howlett JG; Kautzner J; Love CJ; Morgan JM; Priori SG; Reynolds DW; Schoenfeld MH; Vardas PE; ; ; ; ; ; ;
    Europace; 2008 Jun; 10(6):707-25. PubMed ID: 18480075
    [No Abstract]   [Full Text] [Related]  

  • 26. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
    Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
    Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices.
    Lampert R
    Clin Geriatr Med; 2012 Nov; 28(4):693-702. PubMed ID: 23101578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
    Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
    Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
    Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
    G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
    Mueller PS; Hook CC; Hayes DL
    Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.
    Strömberg A; Fluur C; Miller J; Chung ML; Moser DK; Thylén I
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):834-42. PubMed ID: 24483943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.
    Wright GA; Klein GJ; Gula LJ
    Curr Opin Cardiol; 2013 Jan; 28(1):43-9. PubMed ID: 23128499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Deactivating pacemakers in terminally ill patients].
    Hotvedt R
    Tidsskr Nor Laegeforen; 2008 Aug; 128(15):1680. PubMed ID: 18704136
    [No Abstract]   [Full Text] [Related]  

  • 34. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
    Marinskis G; van Erven L;
    Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lost in translation: examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions.
    Mitar M; Alba AC; MacIver J; Ross H
    Circ Heart Fail; 2012 Sep; 5(5):660-6. PubMed ID: 22991406
    [No Abstract]   [Full Text] [Related]  

  • 36. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
    Zellner RA; Aulisio MP; Lewis WR
    Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
    [No Abstract]   [Full Text] [Related]  

  • 37. Deactivation of automatic implantable cardioverter-defibrillators in hospice and home care patients at the end of life.
    Kirk TW
    Home Healthc Nurse; 2008; 26(7):431-7. PubMed ID: 18622221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.
    England R; England T; Coggon J
    J Med Ethics; 2007 Sep; 33(9):538-40. PubMed ID: 17761824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is pacemaker deactivation at the end of life unique? A case study and ethical analysis.
    Whitlock SN; Goldberg IP; Singh JP
    J Palliat Med; 2011 Oct; 14(10):1184-8. PubMed ID: 21882901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pacemakers and end-of-life decisions.
    Lampert R; Hayes D
    JAMA; 2011 May; 305(18):1858-9; author reply 1859. PubMed ID: 21558514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.